Telmisartan
- Generic Name
- Telmisartan
- Brand Names
- Actelsar Hct, Micardis, Micardis-hct, Pritor, Twynsta, Tolura, Kinzalmono (previously Telmisartan Boehringer Ingelheim Pharma KG), Telmisartan Teva Pharma, Telmisartan Actavis
- Drug Type
- Small Molecule
- Chemical Formula
- C33H30N4O2
- CAS Number
- 144701-48-4
- Unique Ingredient Identifier
- U5SYW473RQ
- Background
Telmisartan is an angiotensin II receptor antagonist (ARB) used in the management of hypertension. Generally, angiotensin II receptor blockers (ARBs) such as telmisartan bind to the angiotensin II type 1 (AT1) receptors with high affinity, causing inhibition of the action of angiotensin II on vascular smooth muscle, ultimately leading to a reduction in arter...
- Indication
Used alone or in combination with other classes of antihypertensives for the treatment of hypertension. Also used in the treatment of diabetic nephropathy in hypertensive patients with type 2 diabetes mellitus, as well as the treatment of congestive heart failure (only in patients who cannot tolerate ACE inhibitors).
- Associated Conditions
- Cardiovascular Events, Diabetic Nephropathy, Heart Failure, Hypertension
- Associated Therapies
- -
To Evaluate the Drug-drug Interaction Between Telmisartan and Atorvastatin in Healthy Male Volunteers
- Conditions
- Interventions
- First Posted Date
- 2015-10-19
- Last Posted Date
- 2015-10-19
- Lead Sponsor
- Samil Pharmaceutical Co., Ltd.
- Target Recruit Count
- 48
- Registration Number
- NCT02579356
- Locations
- 🇰🇷
Chonbuk National University Hospital, Seoul, Korea, Republic of
INTERVENCION Trial
- Conditions
- Interventions
- First Posted Date
- 2015-02-26
- Last Posted Date
- 2015-10-21
- Lead Sponsor
- Prevencion
- Target Recruit Count
- 120
- Registration Number
- NCT02373163
- Locations
- 🇵🇪
Centro de Investigacion PREVENCION, Arequipa, AQP, Peru
CKD-828 (80/5mg) Pharmacokinetic Study
- First Posted Date
- 2015-02-09
- Last Posted Date
- 2015-07-08
- Lead Sponsor
- Chong Kun Dang Pharmaceutical
- Target Recruit Count
- 48
- Registration Number
- NCT02358824
- Locations
- 🇰🇷
Kyungpook National University Hospital, Daegu, samdeok-dong, 2-ga 50, samdeok-dong, 2-ga 50 Jung-gu, Korea, Republic of
Study of TelmisartanFor the Prevention of Acute GVHD Post Allogeneic Hematopoietic Stem Cell Transplantation
- First Posted Date
- 2015-01-14
- Last Posted Date
- 2024-05-01
- Lead Sponsor
- Hackensack Meridian Health
- Target Recruit Count
- 32
- Registration Number
- NCT02338232
- Locations
- 🇺🇸
Hackensack University Medical Center, Hackensack, New Jersey, United States
Bioequivalence of Telmisartan as Telmisartan 80 mg/HCTZ 12.5 mg Fixed-dose Combination Tablet or as Two Telmisartan 40 mg Tablets in Healthy Male Volunteers
- First Posted Date
- 2014-10-28
- Last Posted Date
- 2014-10-28
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 64
- Registration Number
- NCT02276391
Relative Bioavailability of Telmisartan and Dipyridamole After Co-administration Compared to the Bioavailability of Telmisartan or Dipyridamole Alone in Healthy Female and Male Subjects
- First Posted Date
- 2014-10-13
- Last Posted Date
- 2014-10-13
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 24
- Registration Number
- NCT02262793
Bioequivalence of Telmisartan / HCTZ of Fixed Dose Combination Compared to Its Monocomponents in Healthy Male Volunteers
- Conditions
- Interventions
- First Posted Date
- 2014-10-13
- Last Posted Date
- 2014-10-13
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 30
- Registration Number
- NCT02262598
Bioequivalence of Telmisartan/ HCTZ Fixed Dose Combination Compared With Its Monocomponents in Healthy Male Volunteers II
- First Posted Date
- 2014-10-13
- Last Posted Date
- 2014-10-13
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 68
- Registration Number
- NCT02262858
Relative Bioavailability of Telmisartan and SR26334 After Co-administration Compared to the Bioavailability of Telmisartan and SR26334 After Administration of Telmisartan and Clopidogrel Alone in Healthy Male and Female Subjects
- First Posted Date
- 2014-10-13
- Last Posted Date
- 2014-10-13
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 24
- Registration Number
- NCT02262650
Bioequivalence of Telmisartan / HCTZ Fixed Dose Combination Compared to Its Monocomponents in Healthy Male Volunteers
- Conditions
- Interventions
- First Posted Date
- 2014-10-13
- Last Posted Date
- 2014-10-13
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 36
- Registration Number
- NCT02262624
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.